These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Randomized trial of tacrolimus versus cyclosporine in steroid withdrawal in living donor renal transplant recipients. Kim SJ; Lee KW; Lee DS; Lee HH; Lee SK; Kim B; Huh WS; Oh HY; Joh JW Transplant Proc; 2004 Sep; 36(7):2098-100. PubMed ID: 15518759 [TBL] [Abstract][Full Text] [Related]
8. Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination. Fortin MC; Raymond MA; Madore F; Fugère JA; Pâquet M; St-Louis G; Hébert MJ Am J Transplant; 2004 Jun; 4(6):946-52. PubMed ID: 15147429 [TBL] [Abstract][Full Text] [Related]
9. Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trial. Hazzan M; Labalette M; Copin MC; Glowacki F; Provôt F; Pruv FR; Noël C J Am Soc Nephrol; 2005 Aug; 16(8):2509-16. PubMed ID: 15987748 [TBL] [Abstract][Full Text] [Related]
11. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients. Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352 [TBL] [Abstract][Full Text] [Related]
12. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study. Abramowicz D; Del Carmen Rial M; Vitko S; del Castillo D; Manas D; Lao M; Gafner N; Wijngaard P; J Am Soc Nephrol; 2005 Jul; 16(7):2234-40. PubMed ID: 15917338 [TBL] [Abstract][Full Text] [Related]